Alzheimer’s disease protein atlas reveals hidden cell-type biology

, , ,

On Nov. 17, 2026, scientists at St. Jude Children’s Research Hospital announced developing a cell type-specific protein atlas using brains from mouse models of Alzheimer’s disease. Alzheimer’s disease can affect almost the entire brain, but how different cell types are specifically affected is not fully understood.

By combining and comparing multiple types of data, they identified over 3,000 proteins with altered levels across a range of cell types, 78% of which had not been captured before. A focused look at microglia, which express many Alzheimer’s disease risk genes, revealed that almost all the changes to this cell type were previously undetected. The approach also uncovered a potential intercellular communication network, where proteins made in one cell type are secreted and function in another cell type. The findings, published in Neuron, provide much-needed cell type-specific context to the pathology of Alzheimer’s disease. 

Single-cell RNA sequencing has revolutionized Alzheimer’s disease research, but it provides only a partial view of cellular activity. Proteomic profiling fills many gaps, but has largely been limited to bulk analysis, resulting in lost context. Now, by combining next-generation mass spectrometry methods with single-cell RNA sequencing and spatial omics, co-corresponding authors Junmin Peng, PhD, Departments of Structural Biology and Developmental Neurobiology and Jiyang Yu, PhD, Department of Computational Biology interim chair, obtained the needed cell type-specific information. 

“This is the first cell-type-resolved proteomic analysis we are aware of in the Alzheimer’s disease field. When we compared our data to bulk datasets, we found that a large portion of the protein level changes we detected are new,” Peng said. “We also identified many potential disease drivers that can be targeted in future follow-up studies.”

Using two Alzheimer’s disease mouse models, the team profiled over 13,000 proteins across multiple ages and cell types. This profiling allowed direct comparison with single-cell RNA sequencing data, identifying thousands of cell type-specific changes in proteins, pathways and intercellular signaling networks.

“Because our lab specializes in deep proteomics, we were able to generate exceptionally robust datasets. That depth allowed meaningful comparisons with RNA data,” said co-first author Xue Zhang, PhD, a postdoctoral researcher in Peng’s lab. “Without sufficient coverage, such integration and analysis would not be possible.”

The atlas and accompanying datasets provide a valuable resource that will allow researchers to make the leap into single-cell analysis in Alzheimer’s disease samples. “True integration has to start with experimental design, not after the data are generated,” said co-first author Jiyuan Yang, PhD, a senior computational research scientist in Yu’s lab. “It also requires a clear understanding of how different types of data can complement and inform each other. We hope our study provides a useful blueprint for future multi-omics research.” 

Tags:


Source: St. Jude Children’s Research Hospital
Credit:

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.